Allosteric role of a structural NADP + molecule in glucose-6-phosphate dehydrogenase activity.
Xuepeng WeiKathryn KixmoellerElana BaltrusaitisXiaolu YangRonen MarmorsteinPublished in: Proceedings of the National Academy of Sciences of the United States of America (2022)
Human glucose-6-phosphate dehydrogenase (G6PD) is the main cellular source of NADPH, and thus plays a key role in maintaining reduced glutathione to protect cells from oxidative stress disorders such as hemolytic anemia. G6PD is a multimeric enzyme that uses the cofactors β-D-glucose 6-phosphate (G6P) and "catalytic" NADP + (NADP + c), as well as a "structural" NADP + (NADP + s) located ∼25 Å from the active site, to generate NADPH. While X-ray crystallographic and biochemical studies have revealed a role for NADP + s in maintaining the catalytic activity by stabilizing the multimeric G6PD conformation, other potential roles for NADP + s have not been evaluated. Here, we determined the high resolution cryo-electron microscopy structures of human wild-type G6PD in the absence of bound ligands and a catalytic G6PD-D200N mutant bound to NADP + c and NADP + s in the absence or presence of G6P. A comparison of these structures, together with previously reported structures, reveals that the unliganded human G6PD forms a mixture of dimers and tetramers with similar overall folds, and binding of NADP + s induces a structural ordering of a C-terminal extension region and allosterically regulates G6P binding and catalysis. These studies have implications for understanding G6PD deficiencies and for therapy of G6PD-mediated disorders.
Keyphrases
- high resolution
- endothelial cells
- oxidative stress
- electron microscopy
- wild type
- type diabetes
- stem cells
- chronic kidney disease
- magnetic resonance imaging
- blood glucose
- induced pluripotent stem cells
- mass spectrometry
- small molecule
- computed tomography
- pluripotent stem cells
- reactive oxygen species
- induced apoptosis
- risk assessment
- crystal structure
- bone marrow
- signaling pathway
- diabetic rats